Skip to main content

Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis

Deliverables

Report on the educational activities and surveys conducted under GLORIA (2)

Report on the educational activities and surveys conducted under GLORIA

Written scientific documents addressing the limitations of current knowledge

Written scientific documents addressing the limitations of current knowledge

Report on the educational activities and surveys conducted under GLORIA (1)

Report on the educational activities and surveys conducted under GLORIA

Report on analysis of existing guidelines and recommendations

Report: Analysis of existing guidelines and recommendations (international and national in participating countries) regarding the role of GC on the treatment of RA, including survey of patients and prescribers on 1. Acceptability and limitations of current recommendations, 2. Information needed to allow improvement of current recommendations

Reports on the progress of GLORIA project at European and American Rheumatology Annual Congresses (2)

Reports on the progress of GLORIA project at European and American Rheumatology Annual Congresses

Report on current status of the involvement of the elderly in clinical trials

Report on current status of the involvement of the elderly in clinical trials

Reports on the progress of GLORIA project at European and American Rheumatology Annual Congresses (1)

Reports on the progress of GLORIA project at European and American Rheumatology Annual Congresses

Scientific content with applicable lay versions made available at website.

Scientific content with applicable lay versions made available at website.

Launch of a web-based survey of patient’s opinions

Launch of a web-based survey of patient’s opinions

Launch of web-based survey

Launch of web-based survey of prescriber’s opinions

Publications

“Official View” on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements

Author(s): Yannick Palmowski, Thomas Buttgereit, Christian Dejaco, Johannes W. Bijlsma, Eric L. Matteson, Marieke Voshaar, Maarten Boers, Frank Buttgereit
Published in: Arthritis Care & Research, Issue 69/8, 2017, Page(s) 1134-1141, ISSN 2151-464X
DOI: 10.1002/acr.23185

Outcome measures for adherence data from a medication event monitoring system: A literature review

Author(s): Linda Hartman, Willem F. Lems, Maarten Boers
Published in: Journal of Clinical Pharmacy and Therapeutics, Issue 44/1, 2019, Page(s) 1-5, ISSN 0269-4727
DOI: 10.1111/jcpt.12757

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Author(s): Hartman, L; Rasch, La; Klausch, T; Bijlsma, Hwj; Christensen, R; Smulders, Ym; Ralston, Sh; Buttgereit, F; Cutolo, M; Da Silva JAP,; Opris, D; Rovenský, J; Szamosi, S; Middelink, Lm; Lems, Wf; Boers, M.
Published in: Trials 2018;19:67., 2018, ISSN 1745-6215
DOI: 10.1186/s13063-017-2396-3

Datasets

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial

Author(s): Linda Hartman; Linda Rasch; Thomas Klausch; Hans Bijlsma; Robin Christensen; Yvo Smulders; Stuart Ralston; Frank Buttgereit; Maurizio Cutolo; Jose Da Silva; Daniela Opris; Jozef Rovenský; Szilvia Szamosi; Leonie Middelink; Willem Lems; Maarten Boers
Published in: Figshare